Monika Tornsen
Director/Board Member presso IMMUNIC, INC.
Profilo
Monika Maria Tornsen is an Independent Director at Immunic, Inc. and President-North America at Calliditas Therapeutics AB.
She was previously Senior Vice President & General Manager-US at Sarepta Therapeutics, Inc., Vice President-Global Therapeutic at Genzyme Corp., and Chief Commercial Officer at Passage Bio, Inc. Tornsen is a graduate of the University of Lund.
Posizioni attive di Monika Tornsen
Società | Posizione | Inizio |
---|---|---|
IMMUNIC, INC. | Director/Board Member | 05/07/2022 |
CALLIDITAS THERAPEUTICS AB | Corporate Officer/Principal | 07/01/2024 |
Precedenti posizioni note di Monika Tornsen
Società | Posizione | Fine |
---|---|---|
PASSAGE BIO, INC. | Corporate Officer/Principal | 01/12/2022 |
SAREPTA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2021 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/01/2019 |
Formazione di Monika Tornsen
University of Lund | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 4 |
---|---|
SAREPTA THERAPEUTICS, INC. | Health Technology |
CALLIDITAS THERAPEUTICS AB | Health Technology |
PASSAGE BIO, INC. | Health Technology |
IMMUNIC, INC. | Health Technology |
Aziende private | 1 |
---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Monika Tornsen